September 15, 2021

Magenta Therapeutics

Magenta Therapeutics Announces IND Clearance For MGTA-117 Targeted Conditioning Clinical Trial

September 15, 2021

Jounce Therapeutics

Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors

September 13, 2021

Casma Therapeutics

Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board

September 10, 2021

Fulcrum Therapeutics

Fulcrum Therapeutics™ Appoints Mel Hayes as Chief Commercial Officer

September 09, 2021

Decibel Therapeutics

Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss

Load More

Sign up for weekly portfolio news.